CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas

CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas

Bibliographic Details
Main Authors:	Lüke, Julia, Vukoja, Vlatka, Brandenbusch, Tim, Nassar, Khaled, Rohrbach, Jens Martin, Grisanti, Salvatore, Lüke, Matthias, Tura, Aysegül
Format:	Online
Language:	English
Published:	BioMed Central 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891917/

Similar Items

Long-Term Survivors with Metastatic Uveal Melanoma
by: Buzzacco, Dominic M, et al.
Published: (2012)

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
by: Schilling, Bastian, et al.
Published: (2015)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
by: Demirci, Hakan, et al.
Published: (2013)

Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression
by: Gangemi, Rosaria, et al.
Published: (2012)

Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
by: Buder, Kristina, et al.
Published: (2013)

Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
by: Valpione, Sara, et al.
Published: (2015)

Biocompatibility of the vital dye Acid Violet-17 on retinal pigment epithelial cells
by: Tura, Ayşegül, et al.
Published: (2016)

iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors
by: Crabb, John W., et al.
Published: (2015)

Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis
by: Calabro, Sarah R., et al.
Published: (2014)

Uveal Melanoma
by: Papastefanou, Vasilios P., et al.
Published: (2011)

Uveal melanoma: Estimating prognosis
by: Kaliki, Swathi, et al.
Published: (2015)

YAP as oncotarget in uveal melanoma
by: Yu, Fa-Xing, et al.
Published: (2014)

New developments in the treatment of metastatic melanoma – role of dabrafenib–trametinib combination therapy
by: Luke, Jason J, et al.
Published: (2014)

Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas
by: Nowak, Marcin, et al.
Published: (2016)

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512
by: Bhatia, Shailender, et al.
Published: (2012)

In vivo Confocal Microscopy in Differentiating Ipilimumab-Induced Anterior Uveitis from Metastatic Uveal Melanoma
by: Kiratli, Hayyam, et al.
Published: (2016)

Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma
by: Piperno-Neumann, Sophie, et al.
Published: (2016)

Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing
by: Kalirai, H, et al.
Published: (2014)

MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma
by: Eldh, Maria, et al.
Published: (2014)

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
by: Zimmer, Lisa, et al.
Published: (2015)

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study
by: Mouriaux, F, et al.
Published: (2016)

Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases
by: Margaret M. Reynolds, et al.
Published: (2017-05-01)

Molecular Bases of Cutaneous and Uveal Melanomas
by: Gaudi, Sudeep, et al.
Published: (2011)

Expression of EpCAM in uveal melanoma
by: Odashiro, Danilo N, et al.
Published: (2006)

Proteomics of Uveal Melanoma: A Minireview
by: Abildgaard, Søren K. O., et al.
Published: (2013)

The genetics of uveal melanoma: current insights
by: Helgadottir, Hildur, et al.
Published: (2016)

Upcoming translational challenges for uveal melanoma
by: Nabil, Amirouchene-Angelozzi, et al.
Published: (2015)

Upcoming translational challenges for uveal melanoma
by: Amirouchene-Angelozzi, Nabil, et al.
Published: (2015)

Prognostic value of legumain in uveal melanoma
by: WU, TONG, et al.
Published: (2016)

Temozolomide for the treatment of metastatic melanoma
by: Quirbt, I., et al.
Published: (2007)

Imaging of metastatic melanoma
by: Michael King, D
Published: (2006)

Amelanotic metastatic cutaneous melanoma*
by: Mendes, Marcela Sena Teixeira, et al.
Published: (2013)

Emergency Surgery for Metastatic Melanoma
by: Mantas, Dimitrios, et al.
Published: (2014)

Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway
by: Chang, Chi-Wu, et al.
Published: (2014)

Nestin depletion induces melanoma matrix metalloproteinases and invasion
by: Lee, Chung-Wei, et al.
Published: (2014)

Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production
by: Zhu, Ping, et al.
Published: (2005)

CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes
by: Zhu, Ping, et al.
Published: (2006)

Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes
by: Wang, Cong-Hua, et al.
Published: (2011)

How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity
by: Grass, G. Daniel, et al.
Published: (2016)

Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features
by: Tian, Xiuyun, et al.
Published: (2015)